Cancer Family
Thymus Neoplasm
CI-CAN-00000366Explore in graph →
Non-malignant104 active trials1 approved drugs1 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000366Explore in graph →
Clinical trials
283 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02220855 | A Study of BKM120 (Buparlisib) in Relapsed or Refractory Thymomas | completed | Phase 2 | 14 | Patrick Joseph Loehrer Sr.OTHER | 1 | Apr 11, 2022 | clinicaltrials |
| NCT00924326 | CAR T Cell Receptor Immunotherapy for Patients With B-cell Lymphoma | completed | Phase 1 / Phase 2 | 43 | National Cancer Institute (NCI)NIH | 1 | Jan 12, 2022 | clinicaltrials |
| Routine Transcervical Thymectomy in MEN-1 Patients |
| completed |
| — |
| 7 |
| National University Health System, SingaporeOTHER |
| 1 |
| Sep 30, 2021 |
| clinicaltrials |
| NCT01953692 | A Trial of Pembrolizumab (MK-3475) in Participants With Blood Cancers (MK-3475-013/KEYNOTE-013) | completed | Phase 1 | 197 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Aug 4, 2021 | clinicaltrials |
| NCT02669017 | Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL) | completed | Phase 1 | 183 | ADC Therapeutics S.A.INDUSTRY | 3 | May 19, 2021 | clinicaltrials |
| NCT02420691 | Ribociclib in Treating Patients With Advanced Neuroendocrine Tumors of Foregut Origin | completed | Phase 2 | 21 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 30, 2020 | clinicaltrials |
| NCT04577495 | Prognostic Factors in Patients Submitted to Surgical Treatment for Thymoma | completed | — | 50 | IRCCS San RaffaeleOTHER | 0 | Oct 8, 2020 | clinicaltrials |
| NCT01102192 | The Role of the Thymus in Myasthenia Gravis | completed | — | 20 | Charite University, Berlin, GermanyOTHER | 1 | Jul 10, 2020 | clinicaltrials |
| NCT02607631 | A Study of Pembrolizumab for Patients With Thymic Epithelial Tumor | completed | Phase 2 | 33 | Samsung Medical CenterOTHER | 0 | Jul 9, 2020 | clinicaltrials |
| NCT00921739 | Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic Malignancies(ESIMRT) | completed | Phase 1 | 24 | Duke UniversityOTHER | 1 | Apr 2, 2020 | clinicaltrials |
| NCT02636556 | Chemoradiotherapy for Limited Advanced Unresectable Thymic Epithelial Tumors | completed | N/A | 56 | Fudan UniversityOTHER | 1 | Feb 7, 2020 | clinicaltrials |
| NCT02652715 | Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma | completed | N/A | 29 | Mayo ClinicOTHER | 1 | Nov 15, 2019 | clinicaltrials |
| NCT00198133 | Phase II Study of Alimta (Pemetrexed) Treatment of Advanced Thymoma and Thymic Carcinoma | completed | Phase 2 | 27 | Patrick Joseph Loehrer Sr.OTHER | 1 | Jul 22, 2019 | clinicaltrials |
| NCT01364727 | A Phase 2 Study of Amrubicin in Relapsed or Refractory Thymic Malignancies | completed | Phase 2 | 33 | Heather WakeleeOTHER | 1 | Apr 16, 2019 | clinicaltrials |
| NCT02623127 | A Study of Sunitinib in Patients With Metastatic or Recurrent Thymic Carcinoma(KOSMIC) | completed | Phase 2 | 25 | Seoul National University HospitalOTHER | 1 | Jan 23, 2019 | clinicaltrials |
| NCT01965119 | Pilot Study of Ruxolitinib in Relapsed or Refractory Hodgkin Lymphoma and Primary Mediastinal Large B-cell Lymphoma(JAK2) | completed | Phase 2 | 20 | Samsung Medical CenterOTHER | 1 | Nov 1, 2018 | clinicaltrials |
| NCT03288662 | Relationship Between Computed Tomography Manifestation and Histopathological Classification of Thymic Epithelial Tumors | completed | N/A | 2 | Military Hospital 103OTHER | 0 | Sep 20, 2017 | clinicaltrials |
| NCT00944567 | A Clinico-Pathologic Study of Primary Mediastinal B-Cell Lymphoma | completed | — | 125 | International Extranodal Lymphoma Study Group (IELSG)OTHER | 4 | Aug 15, 2017 | clinicaltrials |
| NCT02423291 | A Study of SGN-35 (Brentuximab Vedotin) of Patients With Relapsed or Refractory PMLBCL(FIL_SGN01) | completed | Phase 2 | 15 | Fondazione Italiana Linfomi - ETSOTHER | 1 | Jun 26, 2017 | clinicaltrials |
| NCT00332969 | Efficacy of Octreotide Treatment in Patients With Primary Inoperable Thymoma | completed | Phase 2 | 25 | Novartis PharmaceuticalsINDUSTRY | 1 | Mar 31, 2017 | clinicaltrials |
| NCT03078699 | Prospective Study of Stereotactic Body Radiation Therapy for Thymoma Inoma: Therapeutic Effect and Toxicity Assessment | completed | N/A | 32 | Third Military Medical UniversityOTHER | 1 | Mar 13, 2017 | clinicaltrials |
| NCT00965250 | Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously Treated With Chemotherapy | completed | Phase 2 | 49 | National Cancer Institute (NCI)NIH | 1 | Dec 23, 2016 | clinicaltrials |
| NCT01312324 | Neoadjuvant Chemotherapy for Locally Advanced Thymic Cancer | completed | Phase 2 | 27 | Samsung Medical CenterOTHER | 1 | Apr 20, 2016 | clinicaltrials |
| NCT01135849 | B-Receptor Signaling in Cardiomyopathy | completed | — | 99 | Daniel BernsteinOTHER | 1 | Nov 17, 2015 | clinicaltrials |
| NCT00589290 | Belinostat (PXD101) to Treat Tumors of the Thymus at an Advanced Stage | completed | Phase 2 | 41 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2015 | clinicaltrials |
| NCT00387868 | Preoperative Treatment of Patients With High Risk Thymoma | completed | Phase 2 | 21 | Valley Health SystemOTHER | 2 | Dec 9, 2014 | clinicaltrials |
| NCT00532259 | CT-011 MAb in DLBCL Patients Following ASCT | completed | Phase 2 | 72 | CureTech LtdINDUSTRY | 3 | Sep 12, 2014 | clinicaltrials |
| NCT00314873 | Pilot Study of Imatinib (Gleevec) as Treatment for Advanced Thymic Carcinoma | completed | Phase 1 | 11 | Indiana UniversityOTHER | 1 | Jun 3, 2014 | clinicaltrials |
| NCT00369889 | A Study to Test the Safety and Efficacy of Erlotinib Plus Bevacizumab to Treat Advanced Thymoma and Thymic Cancer | completed | Phase 2 | 18 | Indiana UniversityOTHER | 1 | Jun 3, 2014 | clinicaltrials |
| NCT00003662 | Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases | completed | Phase 2 | 90 | Roswell Park Cancer InstituteOTHER | 1 | Mar 7, 2011 | clinicaltrials |
| NCT00990535 | High Dose Somatostatin Analogues in Neuroendocrine Tumors(HIDONET) | completed | Phase 2 | 28 | Federico II UniversityOTHER | 1 | Oct 7, 2009 | clinicaltrials |
| NCT00965627 | Biology of Thymic Tumors | completed | — | 134 | Istituto Clinico HumanitasOTHER | 1 | Aug 28, 2009 | clinicaltrials |
| NCT00558220 | R-MegaCHOP-ESHAP-BEAM in Patients With High-Risk Aggressive B-Cell Lymphomas(R-MCEB) | completed | Phase 2 | 106 | Czech Lymphoma Study GroupOTHER | 1 | Nov 14, 2007 | clinicaltrials |
Data updated 22 days agoSource updated Apr 11, 2022source: clinicaltrials